» Articles » PMID: 17888627

Innate and Adaptive Immune Response to Apoptotic Cells

Overview
Journal J Autoimmun
Date 2007 Sep 25
PMID 17888627
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

The immune system is constantly exposed to dying cells, most of which arise during central tolerance and from effete circulating immune cells. Under homeostatic conditions, phagocytes (predominantly macrophages and dendritic cells) belonging to the innate immune system, rapidly ingest cells and their debris. Apoptotic cell removal requires recognition of altered self on the apoptotic membrane, a process which is facilitated by natural antibodies and serum opsonins. Recognition, may be site and context specific. Uptake and ingestion of apoptotic cells promotes an immunosuppressive environment that avoids inflammatory responses to self-antigens. However, it does not preclude a T cell response and it is likely that constant exposure to self-antigen, particularly by immature dendritic cells, leads to T cell tolerance. Tolerance occurs by several different mechanisms including anergy and deletion (for CD8+T cells) and induction of T regulatory cells (for CD4+T cells). Failed apoptotic cell clearance promotes immune responses to self-antigens, especially when the cellular contents are leaked from the cell (necrosis). Inflammatory responses may be induced by nucleic acid stimulation of Toll like receptors and other immune sensors, specific intracellular proteins and non-protein (uric acid) stimulation of inflammasomes.

Citing Articles

Clones reactive to apoptotic cells and specific chemical adducts are prevalent among human thymic B cells.

Hertel A, Aguiar T, Mashiko S, Nunez S, Moore C, Gao B Front Immunol. 2024; 15:1462126.

PMID: 39497815 PMC: 11532181. DOI: 10.3389/fimmu.2024.1462126.


Tailoring of apoptotic bodies for diagnostic and therapeutic applications:advances, challenges, and prospects.

Miao X, Wu X, You W, He K, Chen C, Pathak J J Transl Med. 2024; 22(1):810.

PMID: 39218900 PMC: 11367938. DOI: 10.1186/s12967-024-05451-w.


Kojic acid reverses LPS-induced neuroinflammation and cognitive impairment by regulating the TLR4/NF-κB signaling pathway.

Ali W, Choe K, Park J, Ahmad R, Park H, Kang M Front Pharmacol. 2024; 15:1443552.

PMID: 39185307 PMC: 11341365. DOI: 10.3389/fphar.2024.1443552.


Modulating Lipid-Polymer Nanoparticles' Physicochemical Properties to Alter Macrophage Uptake.

Bender E, Sircar A, Taubenfeld E, Suggs L ACS Biomater Sci Eng. 2024; 10(5):2911-2924.

PMID: 38657240 PMC: 11195015. DOI: 10.1021/acsbiomaterials.3c01704.


NADPH oxidase exerts a B cell-intrinsic contribution to lupus risk by modulating endosomal TLR signals.

Liu S, Lagos J, Shumlak N, Largent A, Lewis S, Holder U J Exp Med. 2024; 221(4).

PMID: 38442270 PMC: 10913815. DOI: 10.1084/jem.20230774.


References
1.
OBrien B, Geng X, Orteu C, Huang Y, Ghoreishi M, Zhang Y . A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse. J Autoimmun. 2006; 26(2):104-15. DOI: 10.1016/j.jaut.2005.11.006. View

2.
Kawane K, Ohtani M, Miwa K, Kizawa T, Kanbara Y, Yoshioka Y . Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature. 2006; 443(7114):998-1002. DOI: 10.1038/nature05245. View

3.
Blank M, Shoenfeld Y . B cell targeted therapy in autoimmunity. J Autoimmun. 2007; 28(2-3):62-8. DOI: 10.1016/j.jaut.2007.02.001. View

4.
Gallucci S, Lolkema M, Matzinger P . Natural adjuvants: endogenous activators of dendritic cells. Nat Med. 1999; 5(11):1249-55. DOI: 10.1038/15200. View

5.
Pasquali J, Soulas-Sprauel P, Korganow A, Martin T . Auto-reactive B cells in transgenic mice. J Autoimmun. 2007; 29(4):250-6. DOI: 10.1016/j.jaut.2007.07.006. View